Bionano Genomics raises $10M in registered direct offering of ~39.7M shares and warrants

Bionano Genomics, Inc.

Aggregate gross proceeds of ~$10M from sale of 22.9M common shares and 16.78M pre-funded warrants at $0.252/unit.
Each share/pre-funded warrant includes a purchase warrant exercisable at $0.252; warrants require stockholder approval, expire in 5 years.
Closing expected on January 6, 2025; H.C. Wainwright serves as placement agent with 6% cash fee.
Net proceeds to be used for working capital, R&D, debt repayment or redemption, and capital expenditures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.